[Statistical analysis of liver dysfunction in patients with pulmonary tuberculosis using the data base control...

Area of Science:

• Hepatology
• Clinical Medicine
• Medical Informatics

Background:

• Tuberculosis (TB) treatment often involves chemotherapy, which can lead to hepatic dysfunction.
• Early identification of liver dysfunction is crucial for managing TB patients effectively.
• Existing diagnostic methods may not fully capture the nuances of chemotherapy-induced liver injury in TB.

Purpose of the Study:

• To investigate the frequency and contributing factors of hepatic dysfunction in tuberculosis patients receiving chemotherapy.
• To evaluate the relative importance of clinical symptoms versus laboratory findings in diagnosing liver dysfunction.
• To demonstrate the utility of a computerized database system (HEPATOX) in managing and analyzing patient data.

Main Methods:

• Development and utilization of the HEPATOX program for data management and analysis.
• Analysis of data from 377 tuberculosis patients.
• Comparison of clinical signs and laboratory test results for hepatic dysfunction.

Main Results:

• Laboratory diagnosis was found to be more significant than clinical symptoms in identifying hepatic dysfunction.
• Prior history of hepatitis and active inflammation were identified as predisposing factors for liver dysfunction during chemotherapy.
• The study presents a frequency spectrum of clinical and laboratory findings in tuberculous patients with liver dysfunction.

Conclusions:

• The HEPATOX program effectively aids in studying hepatic dysfunction in tuberculosis patients.
• Chemotherapy-induced liver dysfunction in TB patients is influenced by prior hepatitis and active inflammation.
• Computerized systems enhance the efficacy of data analysis in phthisiopulmonology.